PUBLIC COMPANY
saveSHANGHAI HENLIUS BIOTECH
USupdated 3mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
🐶 Hiring Signal
News
- STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and moreAstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run of setbacksstat · 4h ago
comments(0)
5-min edit window · permanent after that